Campbell & CO Investment Adviser LLC Intra Cellular Therapies, Inc. Transaction History

Campbell & CO Investment Adviser LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$64.76 - $79.84 $433,503 - $534,448	-6,694 Reduced 36.32%	11,737 $803,000
Q1 2024 May 10, 2024	BUY	$64.37 - $75.65 $1.19 Million - $1.39 Million	18,431 New	18,431 $1.28 Million
Q1 2023 May 11, 2023	BUY	$43.8 - $56.99 $80,504 - $104,747	1,838 Added 35.87%	6,962 $376,000
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $225,814 - $279,001	5,124 New	5,124 $271,000
Q2 2022 Aug 09, 2022	SELL	$43.0 - $65.64 $1.63 Million - $2.49 Million	-37,863 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$38.74 - $62.09 $1.47 Million - $2.35 Million	37,863 New	37,863 $2.32 Million
Q4 2020 Feb 09, 2021	SELL	$23.34 - $32.22 $195,005 - $269,198	-8,355 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$17.61 - $31.86 $147,131 - $266,190	8,355 New	8,355 $214,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.